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Keeping in mind that the beneﬁts were measured by sur-
vival groups, the cost effectiveness was: €57/month of life
for G1, 181 for G2, and 222 for G3. CONCLUSIONS:
not having an adequate vascular access in order to start
PHD, causes not only an important decrease of survival
but more indirect costs as less beneﬁt too.
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COST-MINIMISATION AND COST-
EFFECTIVENESS ANALYSES
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OBJECTIVES: The costs associated with kidney trans-
plantation are substantial, not only because of trans-
plantation surgery but also due to the life-long need for
immunosuppressive medication to prevent graft rejection.
We analyzed the clinical and economic consequences 
of the use of the two baseline immunosuppressants,
tacrolimus (Tac), and cyclosporin (CyA), currently
administered in clinical practice. METHODS: A retro-
spective economic analysis was performed from a hospi-
tal perspective in Italy, Spain, and Germany. The analysis
was conducted on the ITT-population comprising 557
patients from 7 European countries. Thus, the clinical and
medical resource information for the pharmacoeconomic
analysis was pooled multi-country data, the cost data was
country speciﬁc. Costs were calculated on the actual
resources used by each patient and assigned to the treat-
ment group to which the patient was randomized. Direct
medical resource use data was costed over 6 months post
transplantation. A local health economist collected cost
information from published sources and personal inter-
views with clinicians. Costs were collected on study drug,
concomitant medication, hospitalization, dialysis, and
rejection episodes. To explore the impact of any variabil-
ity of costs, a one-way sensitivity analysis was conducted.
RESULTS: Six months after transplantation, patient sur-
vival was 99.3% (Tac) and 98.5% (CyA), p = 0.366; graft
survival was 94.6% (Tac) and 91.9% (CyA), p = 0.139.
The incidence of acute graft rejection was 32.5% (Tac)
and 51.3% (CyA), p < 0.0001. Cost-minimization analy-
sis revealed savings for tacrolimus (per patient) of
€583–1874 for surviving patients, and €781–2305 for
patients with functioning grafts. Tacrolimus was cost-
effective for patients with rejection-free grafts; savings per
patient were €4627–9919. The tacrolimus group consis-
tently had lower total costs than the cyclosporin group.
The cost advantages for tacrolimus were a result of lower
overall hospitalization costs and lower incidences of dial-
ysis and graft rejection. A sensitivity analysis regarding
the main cost drivers (hospitalization, study drug, and
concomitant medication) generally conﬁrmed the robust-
ness of this ﬁnding in all 3 countries.
URINARY/KIDNEY DISEASES OR DISORDERS—
Quality of Life Studies
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OBJECTIVE: Use of electronic data capture (EDC) in the
assessment of patient status is increasing, however it must
be determined how data collected electronically correlates
with similar data collected using the standard “paper”
method. Our objective was to compare paper and elec-
tronic administrations of a urinary voiding and symptom
diary for use in a population with benign prostatic hyper-
plasia (BPH). METHODS: Using a crossover design, men
aged 45–85 with a diagnosis of BPH and IPSS scores of
8 or greater were recruited from clinics. Subjects com-
pleted either the paper or electronic version of the diary
(depending on randomized arm) for 7 consecutive days
and then the opposing version for the following 7 con-
secutive days. Data quality was assessed for both ver-
sions. Intraclass correlation coefﬁcients (ICC) and t-test
comparisons were calculated to compare EDC and paper
versions for the mean number of urinary events, symp-
toms, and severity of urgency. Ease of use, preference, and
demographic items were also collected. RESULTS: A total
of 28 subjects were assessed with 14 in each group. Mean
age and IPSS for the total sample was 63.8 and 17.3,
respectively. Data quality concerns were minimal with
both versions. Mean differences in urinary events, symp-
toms and severity were not signiﬁcantly different (p-
values > 0.29, ICC > 0.70). Participants who took the
electronic version ﬁrst thought the paper version was con-
siderably less convenient to keep with them and more dif-
ﬁcult to use. The majority of the sample (64%) would
prefer, if given a choice, the computerized version of the
diary compared with 29% opting for the paper version
(7% indicated no real preference for either). CONCLU-
SION: As in previous studies comparing electronic to
paper assessments, this study revealed statistical evidence
to support the use of EDC of a patient urinary diary.
While some difﬁculties existed, the electronic version pro-
duced good data with low data management burden.
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OBJECTIVE: With the progression of the renal insufﬁ-
ciency (RI) produced in the chronic allograft nephropa-
thy (CAN), the patients’ HRQoL worsens. The treatment
of the anemia associated to the RI with rh-EPO improves
the HRQoL. The objective of present study was to eval-
uate the HRQoL of kidney transplant patients with CAN
and anemia associated to the RI, and the effect of the
treatment with rh-EPO on the HRQoL. METHODS:
Prospective study of 24 kidney transplant patients with
RI caused by CAD and anemia who received rh-EPO to
treated the anemia. The hemoglobin target was 12gr/dL.
HRQoL was evaluated with the SF-36 Health Survey at
start treatment, 3 months later and at the end of follow-
up. SF-36 scores (8 dimensions, Physical-PCS and Mental
Component Summary-MCS) were standardized by age
and gender using the Spanish general population norms.
The “Effect Size” was also calculated for each dimension
and for summary scores. RESULTS: Hemoglobin statisti-
cally improved from start to third month (p < 0.01). SF-
36 scores of studied patients were worse than those of the
general population and that those of a transversal sample
of transplant patients with good renal function: PCS =
36.08 ± 12.83 vs. 48.68 ± 9.86; MCS = 47.16 ± 14.46
vs. 51.91 ± 10.25. Three SF-36 dimensions statistically
improved with the correction of anemia with the rh-EPO
treatment: Role Physical, Vitality and Mental Health. The
“Effect Size” was very small for Physical Functioning and
Social Functioning; small for General Health (0.28) and
PCS (0.23); moderate for Pain (0.41), Role Emotional
(0.39) and MCS (0.42); and large for Role Physical
(0.65), Vitality (0.81) and Mental Health (0.74). CON-
CLUSIONS: The poor HRQoL of kidney transplant
patients with CAN and anemia improves with the treat-
ment of the anemia with rh-EPO. The “Effect Size” for
this change in the HRQoL is moderate to large in major-
ity of HRQoL areas.
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OBJECTIVE: A great proportion (50–70%) of patients
with urinay incontinence (UI) do not ask for medical
advise. Symptom questionnaires may help in detecting the
UI. The objective of present study was to analize the psy-
chometric properties of the Spanish version of the ques-
tionnaire of UI symptoms “ICIQ-SF”. METHODS: A
total of 500 women who consulted at a UI-specialized
unit answered the questionnaire. Urodinamic study was
carried out, and sociodemographic and clinical data were
also collected including the symptoms expressed by the
patients. So there were two diagnostic tools for the assess-
ment: clinical and that of the urodinamic study. Feasibil-
ity, validity (comparing the scores between groups ac-
cording to both diagnostic methods, between goups of
different sort of UI and between groups of different sever-
ity degrees) and reliability (Cronbach’s alpha) were
assessed. Sensitivity (Se), speciﬁcity (Sp), positive (PPV)
and negative (NPV) predictive value with respect to clin-
ical diagnostic and that of the urodinamic study were also
calculated. RESULTS: Mean time of administration was
3 minutes. All patients answered all the items of the ICIQ-
SF. According to clinical diagnostic, patients with UI
showed higher score on the ICIQ-SF (11.6 ± 5.9) than
women without UI (4.5 ± 6.3) (p = 0.000). The same
occurs with the groups according to the urodinamic study
(11.1 ± 6.3 vs. 6.2 ± 6.5; p = 0.000). A higher severity
degree was associated to a higher score on the ICIQ-SF:
low degree (10.47 ± 5.61) vs. intermediate (12.4 ± 5.72)
vs high degree (13.61 ± 5.42). Cronbach’s alpha was 0.89.
The values of Se, Sp, PPV and NPV were 92.1%, 55.6%,
88.3% y 65.9% with respect to clinical diagnostic and
87.7%, 40.8%, 85.1% y 46.2% with respect to the uro-
dinamic study. CONCLUSIONS: This is the ﬁrst ques-
tionnaire design for diagnostic of UI validated in Spain.
The psychometric properties of the ICIQ-SF are satisfac-
tory and allow to recommend the use of the questionnaire
in the clinical practice.
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OBJECTIVE: To evaluate the HRQoL of the patients
who started RRT in our region during last 2 years (N =
284) following them along the time and searching for 
differences between elderly (≥65 years) and younger
patients. METHODS: Preliminary results of 66 patients
who remained in HD during one year are shown. Patients
excluded: a total of 8 because of cognitive deterioration.
An interview was carried out at three months from start
and one year later, using the SF-36 Health Survey, obtain-
ing a Physical (PCS) and a Mental (MCS) Component
Summary Scores, and the Physical Symptom scale (PSS)
of the Kidney Disease Questionnaire (KDQ). Sociodemo-
graphic and clinical data, Karnofsky Scale and a com-
orbidity index were also collected. SF-36 scores were
standardized using the Spanish general population norms.
RESULTS: Mean age = 66.8 ± 13.1 years (elderly 71.2%);
56% men. The main analytic and clinical parameters did
not change after one year: hemoglobin = 11.5 ± 1 versus
11.1 ± 1.5gr./dL.; Albumin = 3.6 ± 0.2 versus 3.6 ±
0.4gr./L.; Creatinine = 8.13 ± 2.39 versus 7.87 ±
